Oral contraceptive use has been previously associated with an increased risk of suicidal behavior in some, but not all, samples. The use of large, representative, longitudinally-assessed samples may clarify the nature of this potential association.
Methods
We used Swedish national registries to identify women born between 1991 and 1995 (N = 216 702) and determine whether they retrieved prescriptions for oral contraceptives. We used Cox proportional hazards models to test the association between contraceptive use and first observed suicidal event (suicide attempt or death) from age 15 until the end of follow-up in 2014 (maximum age 22.4). We adjusted for covariates, including mental illness and parental history of suicide.
Results
In a crude model, use of combination or progestin-only oral contraceptives was positively associated with suicidal behavior, with hazard ratios (HRs) of 1.73-2.78 after 1 month of use, and 1.25-1.82 after 1 year of use. Accounting for sociodemographic, parental, and psychiatric variables attenuated these associations, and risks declined with increasing duration of use: adjusted HRs ranged from 1.56 to 2.13 1 month beyond the initiation of use, and from 1.19 to 1.48 1 year after initiation of use. HRs were higher among women who ceased use during the observation period.
Conclusions
Young women using oral contraceptives may be at increased risk of suicidal behavior, but risk declines with increased duration of use. Analysis of former users suggests that women susceptible to depression/anxiety are more likely to cease hormonal contraceptive use. Additional studies are necessary to determine whether the observed association is attributable to a causal mechanism.
oral contraceptive mental health risks, birth control pills suicide risk, hormonal contraception depression young women, contraceptive side effects mood, suicidal behavior hormonal birth control, psychological effects oral contraceptives
Cite this article
Edwards, A., Lönn, S., Crump, C., Moscicki, E., Sundquist, J., Kendler, K. S., & Kristina, S. (2020). Oral contraceptive use and risk of suicidal behavior among young women. *Psychological medicine*, *52*(9), 1710-1717. https://doi.org/10.1017/S0033291720003475
Edwards A, Lönn S, Crump C, Moscicki E, Sundquist J, Kendler KS, et al. Oral contraceptive use and risk of suicidal behavior among young women. Psychol Med. 2020;52(9):1710-1717. doi:10.1017/S0033291720003475
Edwards, Alexis, et al. "Oral contraceptive use and risk of suicidal behavior among young women." *Psychological medicine*, vol. 52, no. 9, 2020, pp. 1710-1717.
Johansson T et al., 2023
Open Access
Epidemiology and Psychiatric Sciences
Aim: Research on the effect of oral contraceptive (OC) use on the risk of depression shows inconsistent findings, especially in adult OC users. One possible reason for this inconsistency is the omissi...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side Effects
Jung SJ et al., 2018Journal of Affective Disorders
Introduction: The association of suicide with the use of oral contraceptives (OC) is unknown in the Asian population. We aimed to evaluate the association of OC use and suicidal behavior in a national...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side Effects
A multinational hospital-based case-control study of the risk of venous thromboembolic disease associated with combined oral contraceptives (OCs) done in 1989-93 prompted a separate inquiry comparing ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionReproductive Endocrinology > Progesterone > Clinical EffectsContraception/Comparison > FABM vs Hormonal > Side Effects
Yonis H et al., 2025
Open Access
BMJ (Clinical Research Ed.)
Objective: To evaluate the association between contemporary hormonal contraceptive use and the risk of incident ischaemic stroke and myocardial infarction.
Design: Real-world, nationwide, prospective ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Prevalence